Clinical Trial Update: Phase III Trial to Assess Efficacy and Safety of Cetuximab for the Treatment of Chinese Participants With Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase III trial evaluating cetuximab for efficacy and safety in Chinese participants with head and neck squamous cell carcinoma has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Cetuximab (cetuximab)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Carcinoma, Squamous Cell of Head and Neck | Phase 3 | Status: COMPLETED | Results posted: 2019-04-16